ARTICLE SUMMARY:
Inflation and FDA workload adjustments will result in fee hikes to device firms starting October 1.
Starting October 1, a standard PMA submission will cost a device company an extra $42,000 in user fees. The hike reflects an across-the-board 9.5% fee increase coming in FY 2024 for all FDA premarket submissions.
